ANIP Stock: Price, Earnings History and SEC Filings
ANI Pharmaceuticals, Inc. (ANIP) last traded at $72.00, down 1.59% on the latest session and down 0.9% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $1.82 against an analyst estimate of $1.67, a beat of 9.0%.
$72.00 -1.59%
1 month-0.89%
52-week high$95.57
52-week low$69.58
Volume286,897
ExchangeNasdaqGM
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
ANIP earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 7, 2026 | $1.82 | $1.67 | +8.98% |
| Mar 2026 | May 8, 2026 | $1.68 | $0.96 | +75.00% |
| Dec 2025 | Feb 27, 2026 | $1.98 | $1.62 | +22.22% |
| Sep 2025 | Nov 7, 2025 | $1.64 | $1.37 | +19.71% |
ANIP beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for ANIP
SEC filing data is not available right now. You can search for ANIP on SEC EDGAR.
ANIP news
- NovoCure (NVCR) Reports Q3 Loss, Tops Revenue EstimatesOct 29, 2026 · finance.yahoo.com
- 3 market-beating stocks for long-term investorsOct 29, 2026 · finance.yahoo.com
- ANI Pharmaceuticals to Discuss Third Quarter 2026 Financial Results on November 5, 2026 at 8:00 a.m. ETOct 23, 2026 · finance.yahoo.com
- ANI Pharmaceuticals Announces the Launch of Duloxetine Delayed-Release CapsulesOct 19, 2026 · finance.yahoo.com
About ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc. (ANIP) is a US-listed public company on Nasdaq.